Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

ASX/CYP stock hub

ASX/CYP has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

ASX/CYPis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

79.5M

Australian Securities Exchange

Market data

Live price

Current market quote for this ticker.

Current price

ASX/CYP

In the news

Latest news · ASX/CYP

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.9P50 20.4P75 41.2

Trailing P/En/a

P25 14.2P50 19.2P75 35.1

ROE-113

P25 -118.7P50 -49.4P75 -1.2

ROIC-72.5

P25 -74.7P50 -33.5P75 0.1

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All ASX/CYP market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

175

Groups with data

Currency

AUD

Showing 175 of 175 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Australia
Country code	AU
Employees	2
Enterprise value	AUD 77M
Exchange	Australian Securities Exchange
Financial currency	AUD
First seen	2026-05-10
Industry	Biotechnology
Isin	AU000000CYP7
Last refreshed	2026-05-10
Market cap	AUD 79.5M
Price	AUD 0.34
Price currency	AUD
Rev Per Employee	843,644.5x
Sector	Healthcare
Sic	2836
Symbol	asx/CYP
Website	https://www.cynata.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-10.56%
EV Earnings	-9.16x
EV/FCF	-9.47x
EV/Sales	45.61x
FCF yield	-10.22%
P/B ratio	23.48x
P/S ratio	47.14x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross margin	100%
Gross Profit	AUD 1.7M
Gross Profit Growth	-10.5%
Gross Profit Growth Q	-10.04%
Gross Profit Growth3 Y	-10.01%
Gross Profit Growth5 Y	0.4%
Net Income	AUD -8.4M
Net Income Growth Quarters	1%
Net Income Growth Years	2%
Pretax Margin	-498.03%
Profit Per Employee	AUD -4.2M
ROA	-62.05
Roa5y	-39.58
ROCE	-254.5
ROE	-113
Roe5y	-69.74
ROIC	-72.47

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-1.35%
Cagr15y	-6.39%
Cagr1y	67.56%
Cagr3y	27.92%
Cagr5y	-10.7%
EPS Growth Quarters	5
EPS Growth Years	2
Revenue Growth	-3.03x
Revenue Growth Q	-10.04x
Revenue Growth Years	0x
Revenue Growth3 Y	-10.01x
Revenue Growth5 Y	0.4x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	AUD 0.19
Assets	AUD 4.5M
Cash	AUD 2.6M
Current Assets	AUD 2.8M
Current Liabilities	AUD 1.1M
Equity	AUD 3.4M
Liabilities	AUD 1.1M
Long Term Assets	AUD 1.7M
Long Term Liabilities	AUD 0
Net Cash	AUD 2.6M
Net Cash By Market Cap	AUD 3.25
Net Cash Growth	-75.37%
Net Debt Equity	AUD -0.76
Tangible Book Value	AUD 3.4M
Tangible Book Value Per Share	AUD 0.01
WACC	10.19

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.49
Net Working Capital	AUD -919,042
Quick ratio	2.36
Working Capital	AUD 1.7M
Working Capital Turnover	AUD 0.3

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-26.09%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-12.73%
1Y total return	67.5%
200-day SMA	0.28
3Y total return	109.38%
50-day SMA	0.32
50-day SMA vs 200-day SMA	50over200
5Y total return	-43.22%
All Time High	5.1
All Time High Change	-93.43%
All Time High Date	2007-12-20
All Time Low	0.08
All Time Low Change	318.75%
All Time Low Date	2012-08-08
ATR	0.03
Beta	1.08
Beta1y	0.9
Beta2y	0.29
Ch YTD	-2.9
High	0.35
High52	0.44
High52 Date	2026-01-06
High52ch	-22.99%
Low	0.32
Low52	0.15
Low52 Date	2025-07-14
Low52ch	131.03%
Ma50ch	3.33%
Price vs 200-day SMA	21.25%
RSI	53.32
RSI Monthly	58.06
RSI Weekly	55.3
Sharpe ratio	1.02x
Sortino ratio	1.68
Total Return	-26.09%
Tr YTD	-2.9
Tr15y	-62.86%
Tr1m	9.84%
Tr1w	4.69%
Tr3m	-2.9%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	AUD -8.6M
Operating margin	-511.1

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	182,795,753%
Shares Insiders	8.5%
Shares Institutions	13.67%
Shares Out	237,454,369
Shares Qo Q	3.54%
Shares Yo Y	26.09%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	AUD -8.4M
Average Volume	256,753.05x
Bv Per Share	0.01
CAPEX	AUD 50,000
Ch10y	-12.99
Ch15y	-66.5
Ch1m	9.84
Ch1w	4.69
Ch1y	67.5
Ch3m	-2.9
Ch3y	109.4
Ch5y	-43.22
Ch6m	45.65
Change	6.35%
Change From Open	6.35
Close	0.32
Days Gap	0
Depreciation Amortization	276,532
Dollar Volume	167,527.8
Earnings Date	2026-05-27
EBIT	AUD -8.6M
EBITDA	AUD -8.3M
EPS	AUD -0.04
F Score	1
FCF	AUD -8.1M
FCF EV Yield	-10.56x
FCF Per Share	AUD -0.03
Financing CF	114,758
Fiscal Year End	June
Founded	2,003
Is Primary Listing	1
Last Earnings Date	2026-02-20
Last Report Date	2025-12-31
Last Split Date	2013-10-31
Last Split Type	Reverse
Ma150	0.3
Ma150ch	9.98%
Ma20	0.33
Ma20ch	1.85%
Net CF	-7,919,609
Next Earnings Date	2026-05-27
Open	0.32
Position In Range	62.5
Price Date	2026-05-08
Ptbv Ratio	23.48
Relative Volume	2.01x
Revenue	1,687,289x
SBC By Revenue	15.43x
Share Based Comp	260,415
Tr6m	45.65%
Volume	500,083
Z Score	-8.39

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does ASX/CYP pay a dividend?

Capital-return profile for this ticker.

Performance

ASX/CYP stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns ASX/CYP?

Insider, institutional, and short-interest positioning.

Institutional ownership

+13.7%

Share of float held by funds and institutions

Insider ownership

+8.5%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+26.1%

Negative means the company is buying back shares.

Technical

ASX/CYP momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

53.3

Neutral momentum band

Price vs 200-day MA

+21.2%

50/200-day relationship not available

Beta (5Y)

1.08

Moves roughly with the market

Sharpe ratio

1.02

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About ASX/CYP

Hub-level FAQ points readers to the deeper analysis pages.

What is the current asx/CYP stock rating?

asx/CYP is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full asx/CYP analysis?

The full report lives at /stocks/asx/CYP/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for asx/CYP?

The latest report frames asx/CYP around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the asx/CYP page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.